Search for: "SCHERING-PLOUGH" Results 281 - 300 of 404
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Feb 2012, 11:11 am by Joe Consumer
Oh yeah, back in 2009, we told you that Merck and Schering-Plough agreed to a $41.5 million settlement (without admitting any wrongdoing), resolving 140 claims brought by insurers and consumers "who bought, used, or paid money toward the purchase of Vytorin and Zetia" because the companies buried (for about two years) an unfavorable study that showed the companies' jointly marketed cholesterol drugs, Vytorin and Zetia "were no more effective in unclogging… [read post]
20 Apr 2010, 7:30 am by David Walk
The court cited two other cases that had reached the same conclusion: Schering-Plough Healthcare Prods., Inc. v. [read post]
27 Jun 2006, 1:44 pm
-Brian Sipe (Philadelphia, PA - www.attorneysipe.com)No letter from a fellow attorney is complete without a plug to his firm's website.As you can read, this e-mail was much longer, but needed to be cut else this entry would be too long.Part of what's missing in the Slate article referred to on Schering-Plough, the FTC, and the DOJ is the relationship between all intellectual property laws and and anti-trust laws like the Sherman Act. [read post]
29 Nov 2007, 2:29 pm
FDA staffers said no date for the meeting has been set.Those "other" asthma drugs to be consider at this future FDA meeting would be GSK's Advair and Foradil, made by Novartis AG (NVS) and sold in the U.S. by Schering-Plough Corp.As for the suggestion that Serevent and Advair should be recalled from the market, this idea was rejected by an FDA official and a GSK representative. [read post]
13 Oct 2008, 9:59 pm
Last winter, Merck and Schering-Plough were criticized for delaying the release of a study on their best-selling cholesterol medication Vytorin that showed the drug did not slow the growth of plaque in arteries. [read post]
16 Aug 2009, 2:20 am
" Schering-Plough Corp.'s Marvelon and Cerazette pills, which contain desogestrel, generated $319 million for the Kenilworth, New Jersey-based company in the first quarter, IMS Health data show. [read post]
29 Feb 2012, 11:11 am by Joe Consumer
Oh yeah, back in 2009, we told you that Merck and Schering-Plough agreed to a $41.5 million settlement (without admitting any wrongdoing), resolving 140 claims brought by insurers and consumers "who bought, used, or paid money toward the purchase of Vytorin and Zetia" because the companies buried (for about two years) an unfavorable study that showed the companies' jointly marketed cholesterol drugs, Vytorin and Zetia "were no more effective in unclogging… [read post]
20 Aug 2010, 12:56 pm by Stephen Albainy-Jenei
Significant Case Studies Give You The Chance To Learn About New Partnerships and New Agreements In The Industry * BMS and Allergan * Merck and Schering-Plough * Sanofi-Aventis and Intelliject * J&J and Takeda * Eli Lilly and Kowa Pharmaceuticals * Eli Lilly and Incyte Corporation The Perfect Pitch: Biotech Investment Challenge In this groundbreaking session, Biotech companies will have the chance to present your new research and new therapies (either in early stages or mid-late… [read post]
20 Jun 2011, 1:31 pm by VMaryAbraham
The biggest organizational challenge has been that the rollout of these social business tools occured at the same time as Merck was merging with Schering Plough. [read post]
4 Sep 2008, 1:06 am
  Negative press has made Schering-Plough's stock "radioactive. [read post]
28 Mar 2011, 1:57 pm by Tom Lamb
., Organon International (collectively, “Organon”), and Schering-Plough arising from Organon’s marketing and sale of NuvaRing, a combined hormonal contraceptive vaginal ring.... [read post]
9 Oct 2011, 4:35 pm by Lawrence B. Ebert
Schering-Plough and Wyeth added jobs - and subsequently were swallowed Merck and Pfizer, respectively. [read post]
19 Jul 2012, 1:17 pm by Bexis
  Moreover, given the Third Circuit’s intervening standing decision in In re Schering Plough Corp. [read post]
8 Dec 2010, 10:42 am by FDABlog HPM
Geneva Pharms., Inc., 344 F.3d 1294, 1303 (11th Cir. 2003) and in Schering-Plough Corp. v. [read post]
7 Sep 2008, 2:47 pm
For example, let's look at Schering-Plough's "49 Plan," which was an aggressive seven-week sales push to increase Zetia prescriptions across the country. [read post]
19 Jul 2012, 1:17 pm by Bexis
  Moreover, given the Third Circuit’s intervening standing decision in In re Schering Plough Corp. [read post]
9 Nov 2009, 6:01 am
By David Evans Nov. 9 (Bloomberg) -- Prosecutor Michael Loucks remembers clearly when lawyers for Pfizer Inc., the world's largest drug company, looked across the table and promised it wouldn't break the law again. [read post]